APA

Maat-Kievit A., Helderman-van den Enden P., Losekoot M., de Knijff P., Belfroid R., Vegter-van der Vlis M., Roos R. & Breuning M. (20020305). Using a roster and haplotyping is useful in risk assessment for persons with intermediate and reduced penetrance alleles in Huntington disease. : American journal of medical genetics.

Chicago

Maat-Kievit A, Helderman-van den Enden P, Losekoot M, de Knijff P, Belfroid R, Vegter-van der Vlis M, Roos R and Breuning M. 20020305. Using a roster and haplotyping is useful in risk assessment for persons with intermediate and reduced penetrance alleles in Huntington disease. : American journal of medical genetics.

Harvard

Maat-Kievit A., Helderman-van den Enden P., Losekoot M., de Knijff P., Belfroid R., Vegter-van der Vlis M., Roos R. and Breuning M. (20020305). Using a roster and haplotyping is useful in risk assessment for persons with intermediate and reduced penetrance alleles in Huntington disease. : American journal of medical genetics.

MLA

Maat-Kievit A, Helderman-van den Enden P, Losekoot M, de Knijff P, Belfroid R, Vegter-van der Vlis M, Roos R and Breuning M. Using a roster and haplotyping is useful in risk assessment for persons with intermediate and reduced penetrance alleles in Huntington disease. : American journal of medical genetics. 20020305.